Novo Nordisk (NVO) stock is in focus as the company launches a Wegovy subscription program via telehealth firms including Hims & Hers (HIMS). Read more here.

Hims & Hers Health (NYSE:HIMS) is expanding access to FDA-approved GLP-1 medications through a new collaboration with Novo ...

Need a solution for your thinning hair line? We took a deep dive into Hims hair growth program to see how it works and who it ...

Hims is making GLP‑1 weight loss more accessible for men with a new membership starting at $39 for the first month. Here’s ...

In late March 2026, Hims & Hers Health, Inc. announced a renewed collaboration with Novo Nordisk to offer a broad range of FDA-approved GLP-1 medications, including Wegovy injections and the only ...

Few people consult a doctor before attempting weight loss. Hims offers virtual weight loss support for men, including consultations and prescriptions. Hims provides GLP-1 injections, meal replacements ...